Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors

J Baselga, A Cervantes, E. Martinelli, I. Chirivella, K. Hoekman, H.I. Hurwitz, D.I. Jodrell, P. Hamberg, E. Casado, P. Elvin, A. Swaisland, R. Iacona, J. Tabernero

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4876-4883
JournalClinical Cancer Research
Issue number19
Publication statusPublished - 2010

Cite this